How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis.
about
What are the benefits of cognitive enhancers for Alzheimer's Disease: use of Population Impact Measures.Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.Improving clinical descriptions to understand the effects of dementia treatment: consensus recommendations.A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease.Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.Herbal medicine in the treatment of Alzheimer's disease.Use of acetylcholinesterase inhibitors in Alzheimer's disease.Follow-up for Alzheimer patients: European Alzheimer Disease Consortium position paper.Utility of an effect size analysis for communicating treatment effectiveness: a case study of cholinesterase inhibitors for Alzheimer's disease.Efficacy of Ginkgo biloba extract EGb 761(®) in dementia with behavioural and psychological symptoms: A systematic review.A new paradigm for deriving and analyzing number needed to treat.Antiamnesic Effects of Walnuts Consumption on Scopolamine-Induced Memory Impairments in RatsAnxiety can be a harbinger of early onset dementia.Acetylcholinesterase treatment--modelling potential demand and auditing practice.Dementia: issues in early recognition and intervention in primary care.
P2860
Q33305144-311FA8C2-5E27-4998-B0B4-61036352AAE7Q34315588-824DE469-16E0-4975-ACFB-D21EC8D8F041Q34648742-8D57D509-1C67-4F1E-B6F4-74774C90F45DQ34982567-6003AE70-A80A-443F-89CB-C3AD3A5B06D6Q35236228-B6D5F445-3C08-4DB7-AF6A-0C98112C03AAQ35748293-4F283A83-EB03-4877-BFF0-D802A3A40F36Q36458304-B2145B43-6760-42C4-BB1F-D9747CD6EADDQ37610295-723B6BEC-8A6C-48E4-8F18-DA03D1AB4934Q37686190-6D9520AA-9A1A-45D8-BC3B-5AC382265437Q38109708-7C147493-23F7-4B89-9AB7-FF2A4D4884F7Q38557137-C5DF1EF4-3107-4BAC-AE34-612E92A48A6BQ40337127-6827789D-63AC-4752-8CB6-8A2D76CDE0C4Q41835947-B598F706-96E0-435B-94CE-2212106289BCQ51934397-0B0E71D6-1892-4DA7-B1BB-5BC91AAE0967Q51961414-E2BA8355-2B07-498E-896B-A3873E78CD7DQ53882631-8DFD1196-34EB-456B-BE4F-EA2DA8EAE7A0
P2860
How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
How useful are cholinesterase ...... mber needed to treat analysis.
@ast
How useful are cholinesterase ...... mber needed to treat analysis.
@en
type
label
How useful are cholinesterase ...... mber needed to treat analysis.
@ast
How useful are cholinesterase ...... mber needed to treat analysis.
@en
prefLabel
How useful are cholinesterase ...... mber needed to treat analysis.
@ast
How useful are cholinesterase ...... mber needed to treat analysis.
@en
P2860
P1476
How useful are cholinesterase ...... mber needed to treat analysis.
@en
P2093
Livingston G
P2860
P304
P356
10.1002/(SICI)1099-1166(200003)15:3<203::AID-GPS100>3.0.CO;2-9
P407
P577
2000-03-01T00:00:00Z